Prudential PLC Purchases Shares of 15,108 Amrize Ltd $AMRZ

Prudential PLC purchased a new position in shares of Amrize Ltd (NYSE:AMRZFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,108 shares of the company’s stock, valued at approximately $754,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Allspring Global Investments Holdings LLC purchased a new stake in shares of Amrize during the 2nd quarter worth about $62,646,000. Credit Industriel ET Commercial acquired a new position in shares of Amrize during the second quarter worth $109,000. TD Asset Management Inc purchased a new position in Amrize in the 2nd quarter valued at about $8,190,000. Generali Asset Management SPA SGR purchased a new position in Amrize in the second quarter valued at about $4,923,000. Finally, Allianz Asset Management GmbH purchased a new position in shares of Amrize during the 2nd quarter valued at approximately $158,530,000.

Amrize Trading Up 2.1%

AMRZ stock opened at $48.14 on Monday. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. Amrize Ltd has a one year low of $44.12 and a one year high of $56.29. The stock has a market capitalization of $26.63 billion and a price-to-earnings ratio of 26.16. The firm’s 50-day moving average price is $49.43.

Amrize (NYSE:AMRZGet Free Report) last released its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.03). The firm’s revenue was up 6.6% compared to the same quarter last year.

Insider Activity

In other Amrize news, Director Nicholas C. Gangestad bought 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, with a total value of $94,680.00. Following the completion of the transaction, the director directly owned 4,958 shares in the company, valued at approximately $234,711.72. This represents a 67.61% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CTO Roald Brouwer purchased 4,000 shares of the company’s stock in a transaction that occurred on Friday, October 31st. The shares were acquired at an average cost of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the transaction, the chief technology officer directly owned 9,000 shares of the company’s stock, valued at $465,930. This trade represents a 80.00% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders bought 67,000 shares of company stock worth $3,503,480.

Wall Street Analyst Weigh In

AMRZ has been the subject of a number of research reports. Barclays assumed coverage on Amrize in a research note on Tuesday, October 7th. They issued an “equal weight” rating for the company. Oddo Bhf began coverage on shares of Amrize in a research report on Monday, November 3rd. They issued a “neutral” rating on the stock. Citigroup boosted their price target on Amrize from $60.00 to $63.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. UBS Group raised their price objective on shares of Amrize from $52.00 to $53.00 and gave the company a “neutral” rating in a research note on Monday, November 3rd. Finally, Wells Fargo & Company lifted their target price on Amrize from $57.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $58.88.

Read Our Latest Stock Analysis on Amrize

About Amrize

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.